Zenas BioPharma, Inc. ZBIO
28.26 USD +2.33 (+8.99%)
At closeNov 6, 2026, 4:50 PM EST
28.26 0.00 0.00%
After hours · Nov 6, 4:50 PM ET
25.94 Day range 28.44
15.20 52-week range 43.17
- YTD
- -22.17%
- 1 year
- -12.94%
Financial health
Altman Z-Score
-1.31 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -4.3×
FY 2022 5y median -5.0× FY 2025
P/S 162×
FY 2022 5y median 41.1× FY 2025
P/B 6.7×
FY 2022 5y median -1.0× FY 2025
P/FCF -9.4×
FY 2022 5y median -9.8× FY 2025
EV/EBITDA -4.3×
FY 2022 5y median -6.3× FY 2025
EV/Sales 159×
FY 2022 5y median 8.9× FY 2025
FCF Yield -10.6%
FY 2022 5y median -10.2% FY 2025
Profitability
Gross Margin 100.0%
FY 2022 5y median 50.0% FY 2025
Operating Margin -2113.8%
FY 2022 5y median -1094.1% FY 2025
Net Margin -3777.4%
FY 2022 5y median -1607.0% FY 2025
ROE -156.0%
FY 2022 5y median -16.9% FY 2025
ROIC -65.6%
FY 2022 5y median -73.6% FY 2025
ROA -98.5%
FY 2022 5y median -76.5% FY 2025
Growth (YoY)
Revenue 100.0%
FY 2022 FY 2025
Operating Income -29.0%
FY 2022 FY 2025
EPS (diluted) -124.5%
FY 2022 FY 2025
Free Cash Flow -43.9%
FY 2022 FY 2025
Financial Health
Current Ratio 5.6×
FY 2022 5y median 4.1× FY 2025
Quick Ratio 5.6×
FY 2022 5y median 4.1× FY 2025
Debt / Equity 0.3×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2022 5y median 1.1× FY 2025
Interest Coverage -28.9×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31